Allied Market Research published a report, titled, “Genetic Testing Market by Type (Predictive & Pre-Symptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), and Applicatio.
SALT LAKE CITY, Nov. 20, 2023 Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced it has delivered results to one million consumers with its.
Integrating complementary and alternative therapies, psychological support, and nutrition into cancer care can enhance overall patient well being and create opportunities for holistic cancer care centers.Wilmington, Delaware, United States, Nov. 02, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The global ovarian cancer treatment market was estimated to have acquired US$ 5.1 billion in 2022. It is anticipated to register a 15.4% CAGR from 2023 to 2031 and by 2031, the market is li
/PRNewswire/ The "United States Women Health Laboratory Testing Market by Hereditary Cancer, Reproductive Health and Infectious Diseases, Prenatal Screening.